Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 10
- 0 vs. Q2 2022
- Portfolio value
- $107.7M
- −$9.86M (−8.4%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $29.3M | 27.2% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,336,909 | $27.8M | 25.8% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,261,261 | $10.8M | 10.0% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 432,900 | $10.4M | 9.7% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 746,674 | $9.77M | 9.1% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 980,894 | $9.28M | 8.6% | 00.0% | Unchanged | History |
| FFBCFirst Financial Bancorp | COM | 173,576 | $3.66M | 3.4% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 915,705 | $2.66M | 2.5% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 747,550 | $2.39M | 2.2% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 802,963 | $1.62M | 1.5% | 00.0% | Unchanged | History |